Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in northern California

被引:112
作者
Mast, EE
Kuramoto, IK
Favorov, MO
Schoening, VR
Burkholder, BT
Shapiro, CN
Holland, PV
机构
[1] SACRAMENTO MED FDN,CTR BLOOD,SACRAMENTO,CA
[2] SACRAMENTO MED FDN,CTR BLOOD RES,SACRAMENTO,CA
关键词
D O I
10.1086/514037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To evaluate antibody to hepatitis E virus (anti-HEV) seroreactivity, 5000 US blood donors were tested for anti-HEV by two EIAs: a mosaic protein assay (MPr-EIA) and a recombinant protein assay (RPr-EIA). Overall, 59 (1.2%) were seroreactive by MPr-EIA and 70 (1.4%) were seroreactive by RPr-EIA, The overall concordance between tests was 98.5% (4925/5000); the concordance among reactive sera by either test was only 27% (27/102). In a case-control study, seroreactive persons were more likely than seronegative persons to have traveled to countries in which HEV is endemic (odds ratio [OR] for MPr-EIA = 4.3, P < .001; OR for RPr-EIA = 2.5, P = .005), but 31% of MPr-EIA anti-HEV-reactive persons and 38% of RPr-EIA anti-HEV-reactive persons had no history of international travel, These findings suggest that travelers to regions in which HEV is endemic can acquire subclinical HEV infection. The significance of anti-HEV seroreactivity among persons without an international travel history needs to be determined.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 43 条
  • [1] AGE-SPECIFIC PREVALENCE OF ANTIBODIES TO HEPATITIS-A AND HEPATITIS-E VIRUSES IN PUNE, INDIA, 1982 AND 1992
    ARANKALLE, VA
    TSAREV, SA
    CHADHA, MS
    ALLING, DW
    EMERSON, SU
    BANERJEE, K
    PURCELL, RH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 447 - 450
  • [2] Chadha M S, 1991, J Assoc Physicians India, V39, P651
  • [3] FOLLOW-UP STUDY OF CASES FROM DELHI EPIDEMIC OF INFECTIOUS HEPATITIS OF 1955-6
    CHUTTANI, HK
    SIDHU, AS
    WIG, KL
    GUPTA, DN
    RAMALINGASWAMI, V
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1966, 2 (5515): : 676 - +
  • [4] DETECTION OF HEPATITIS-E VIRUS-INFECTIONS AMONG DOMESTIC SWINE IN THE KATHMANDU VALLEY OF NEPAL
    CLAYSON, ET
    INNIS, BL
    MYINT, KSA
    NARUPITI, S
    VAUGHN, DW
    GIRI, S
    RANABHAT, P
    SHRESTHA, MP
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (03) : 228 - 232
  • [5] ABO BLOOD-GROUPS AND CHOLERA - NEW OBSERVATIONS ON SPECIFICITY OF RISK AND MODIFICATION OF VACCINE EFFICACY
    CLEMENS, JD
    SACK, DA
    HARRIS, JR
    CHAKRABORTY, J
    KHAN, MR
    HUDA, S
    AHMED, F
    GOMES, J
    RAO, MR
    SVENNERHOLM, AM
    HOLMGREN, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) : 770 - 773
  • [6] HEPATITIS TYPE-E IN A FRENCH POPULATION - DETECTION OF ANTI-HEV BY A SYNTHETIC PEPTIDE-BASED ENZYME-LINKED-IMMUNOSORBENT-ASSAY
    COURSAGET, P
    DEPRIL, N
    BUISSON, Y
    MOLINIE, C
    ROUE, R
    [J]. RESEARCH IN VIROLOGY, 1994, 145 (01): : 51 - 57
  • [7] SOLID-PHASE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HEPATITIS-E VIRUS IGG AND IGM ANTIBODIES UTILIZING RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES
    DAWSON, GJ
    CHAU, KH
    CABAL, CM
    YARBOUGH, PO
    REYES, GR
    MUSHAHWAR, IK
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1992, 38 (01) : 175 - 186
  • [8] EPIDEMIC NON-A, NON-B HEPATITIS IN PATIENTS FROM PAKISTAN
    DECOCK, KM
    BRADLEY, DW
    SANDFORD, NL
    GOVINDARAJAN, S
    MAYNARD, JE
    REDEKER, AG
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 227 - 230
  • [9] Favorov MO, 1996, J MED VIROL, V50, P50, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt
  • [10] 50::AID-JMV10&gt